Jacobs Levy Equity Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-729,281
Closed -$6.8M – 987
2025
Q4
$6.8M Buy
+729,281
New +$6.09M 0.03% 351

Other funds holding DAWN

Jacobs Levy Equity Management's DAWN Position: Q1 2026 in Review

Jacobs Levy Equity Management sold out of Day One Biopharmaceuticals (DAWN) in Q1 2026, closing a stake of 729,281 shares — an estimated $6.8M sold.

Jacobs Levy Equity Management first reported a position in DAWN in Q4 2025 and held it in 1 quarter. The position peaked at $6.8M in Q4 2025. 208 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Jacobs Levy Equity Management reported no remaining Day One Biopharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 729,281 Day One Biopharmaceuticals shares in Q1 2026, an estimated $6.8M.
  • Jacobs Levy Equity Management first reported a position in Day One Biopharmaceuticals in Q4 2025 and held it in 1 quarter.
  • Jacobs Levy Equity Management's Day One Biopharmaceuticals position peaked at $6.8M in Q4 2025.
  • 208 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.